Literature DB >> 29204332

Estimating Effects of Dynamic Treatment Strategies in Pharmacoepidemiologic Studies with Time-varying Confounding: A Primer.

Xiaojuan Li1, Jessica G Young1, Sengwee Toh1.   

Abstract

PURPOSE OF REVIEW: Pharmacoepidemiologists are often interested in estimating the effects of dynamic treatment strategies, where treatments are modified based on patients' evolving characteristics. For such problems, appropriate control of both baseline and time-varying confounders is critical. Conventional methods that control confounding by including time-varying treatments and confounders in an outcome regression model may not have a causal interpretation, even when all baseline and time-varying confounders are measured. This problem occurs when time-varying confounders are, themselves, affected by past treatment. We review alternative analytic approaches that can produce valid inferences in the presence of such confounding. We focus on the parametric g-formula and inverse probability weighting of marginal structural models, two examples of Robins' g-methods. RECENT
FINDINGS: Unlike standard outcome regression methods, the parametric g-formula and inverse probability weighting of marginal structural models can estimate the effects of dynamic treatment strategies and appropriately control for measured time-varying confounders affected by prior treatment. Few applications of g-methods exist in the pharmacoepidemiology literature, primarily due to the common use of administrative claims data, which typically lack detailed measurements of time-varying information, and the limited availability of or familiarity with tools to help perform the relatively complex analysis. These barriers may be overcome with the increasing availability of data sources containing more detailed time-varying information and more accessible learning tools and software.
SUMMARY: With appropriate data and study design, g-methods can improve our ability to make causal inferences on dynamic treatment strategies from observational data in pharmacoepidemiology.

Entities:  

Keywords:  Causal Inference; Dynamic Treatment Strategies; G-methods; Pharmacoepidemiology; Time-varying Confounding

Year:  2017        PMID: 29204332      PMCID: PMC5710813          DOI: 10.1007/s40471-017-0124-x

Source DB:  PubMed          Journal:  Curr Epidemiol Rep


  56 in total

1.  Improving chronic illness care: translating evidence into action.

Authors:  E H Wagner; B T Austin; C Davis; M Hindmarsh; J Schaefer; A Bonomi
Journal:  Health Aff (Millwood)       Date:  2001 Nov-Dec       Impact factor: 6.301

2.  Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

Authors:  M A Hernán; B Brumback; J M Robins
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

3.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

4.  A structural approach to selection bias.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz; James M Robins
Journal:  Epidemiology       Date:  2004-09       Impact factor: 4.822

Review 5.  A review of uses of health care utilization databases for epidemiologic research on therapeutics.

Authors:  Sebastian Schneeweiss; Jerry Avorn
Journal:  J Clin Epidemiol       Date:  2005-04       Impact factor: 6.437

Review 6.  Comparison of dynamic treatment regimes via inverse probability weighting.

Authors:  Miguel A Hernán; Emilie Lanoy; Dominique Costagliola; James M Robins
Journal:  Basic Clin Pharmacol Toxicol       Date:  2006-03       Impact factor: 4.080

7.  Doubly robust estimation in missing data and causal inference models.

Authors:  Heejung Bang; James M Robins
Journal:  Biometrics       Date:  2005-12       Impact factor: 2.571

8.  Estimation and extrapolation of optimal treatment and testing strategies.

Authors:  James Robins; Liliana Orellana; Andrea Rotnitzky
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

9.  Constructing inverse probability weights for marginal structural models.

Authors:  Stephen R Cole; Miguel A Hernán
Journal:  Am J Epidemiol       Date:  2008-08-05       Impact factor: 4.897

10.  Evaluating medication effects outside of clinical trials: new-user designs.

Authors:  Wayne A Ray
Journal:  Am J Epidemiol       Date:  2003-11-01       Impact factor: 4.897

View more
  3 in total

1.  Diagnosing Covariate Balance Across Levels of Right-Censoring Before and After Application of Inverse-Probability-of-Censoring Weights.

Authors:  John W Jackson
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

2.  Safety of Dynamic Intravenous Iron Administration Strategies in Hemodialysis Patients.

Authors:  Xiaojuan Li; Stephen R Cole; Abhijit V Kshirsagar; Jason P Fine; Til Stürmer; M Alan Brookhart
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-15       Impact factor: 8.237

Review 3.  Longitudinal Methods for Modeling Exposures in Pharmacoepidemiologic Studies in Pregnancy.

Authors:  Mollie E Wood; Angela Lupattelli; Kristin Palmsten; Gretchen Bandoli; Caroline Hurault-Delarue; Christine Damase-Michel; Christina D Chambers; Hedvig M E Nordeng; Marleen M H J van Gelder
Journal:  Epidemiol Rev       Date:  2022-01-14       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.